LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases
Authors
Keywords
Stereotactic radiotherapy, Vemurafenib, Brain metastases, Stereotactic radiosurgery
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 122, Issue 1, Pages 121-126
Publisher
Springer Nature
Online
2014-12-18
DOI
10.1007/s11060-014-1685-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutis Verticis Gyrata in Association With Vemurafenib and Whole-Brain Radiotherapy
- (2014) James J. Harding et al. JOURNAL OF CLINICAL ONCOLOGY
- Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
- (2013) Reinhard Dummer et al. EUROPEAN JOURNAL OF CANCER
- Severe Liver and Skin Toxicity After Radiation and Vemurafenib in Metastatic Melanoma
- (2013) Christopher J. Anker et al. JOURNAL OF CLINICAL ONCOLOGY
- Vemurafenib and radiation therapy in melanoma brain metastases
- (2013) Ashwatha Narayana et al. JOURNAL OF NEURO-ONCOLOGY
- Unusual acute and delayed skin reactions during and after whole-brain radiotherapy in combination with the BRAF inhibitor vemurafenib
- (2013) B. Schulze et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Vemurafenib and Radiosensitization
- (2013) Lise Boussemart et al. JAMA Dermatology
- Cutaneous Toxic Effects Associated With Vemurafenib and Inhibition of the BRAF Pathway
- (2012) Victor Huang et al. ARCHIVES OF DERMATOLOGY
- Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
- (2012) Georgina V Long et al. LANCET ONCOLOGY
- Melanoma Brain Metastases and Vemurafenib: Need for Further Investigation
- (2012) Nicole M. Rochet et al. MAYO CLINIC PROCEEDINGS
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib for Melanoma Metastases to the Brain
- (2011) Nicole M. Rochet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032
- (2011) Maria J. Sambade et al. RADIOTHERAPY AND ONCOLOGY
- Determinants of survival in patients with brain metastases from cutaneous melanoma
- (2010) M Staudt et al. BRITISH JOURNAL OF CANCER
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More